Weitz Marcus, Schmidt Maria
Department of Nephrology, University Children's Hospital Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland.
Eur J Pediatr. 2017 Jan;176(1):1-9. doi: 10.1007/s00431-016-2818-3. Epub 2016 Nov 25.
Ureteropelvic junction obstruction (UPJO) and vesicoureteral reflux (VUR) are the most common uropathies. The co-occurrence of both anomalies has led to the practice of screening for VUR in children with UPJO to prevent deterioration of kidney function due to renal scarring following urinary tract infections (UTIs). We determined the prevalence of VUR in children with UPJO for a critical assessment of VUR screening by voiding cystourethrography (VCUG). A systematic search strategy in MEDLINE, EMBASE, and CENTRAL was carried out for all articles that included VCUG, and renal scintigraphy or any other appropriate imaging technique for the diagnosis of UPJO. Twenty studies were eligible for inclusion. We found a pooled prevalence for VUR of 8.2 % (95 % CI = 3.6-12.7), about a threefold increase compared to the general pediatric population. VUR occurred bilateral or contralateral to the kidney with UPJO in 5.7 % (95 % CI = 3.0-8.5), equivalent to 75 % of all children with VUR. Considering the effect size of VUR treatment with antibiotics, about 207 and 278 children would need to undergo VCUG to prevent one febrile UTI and one case of renal scarring by 1-2 years, respectively.
Against this background, screening for VUR needs to be scrutinized and restricted to selected risk groups. What is known: • Screening of patients with ureteropelvic junction obstruction (UPJO) for vesicoureteral reflux (VUR) is recommended based on a small number of repeatedly cited studies. • The lack of conclusive evidence results in different treatment strategies and leads to difficulties when communicating diagnoses and treatment options to parents. What is new: • A robust prevalence for VUR in children with UPJO based on all published evidence and the resulting number needed to screen are given for decision-making in daily clinical practice. • The results may be a precursor for implementation into guidelines.
肾盂输尿管连接部梗阻(UPJO)和膀胱输尿管反流(VUR)是最常见的泌尿系统疾病。这两种异常同时出现导致了对UPJO患儿进行VUR筛查的做法,以预防尿路感染(UTIs)后因肾瘢痕形成而导致的肾功能恶化。我们确定了UPJO患儿中VUR的患病率,以便通过排尿性膀胱尿道造影(VCUG)对VUR筛查进行批判性评估。我们在MEDLINE、EMBASE和CENTRAL中进行了系统的检索策略,查找所有包括VCUG以及肾闪烁显像或任何其他用于诊断UPJO的适当成像技术的文章。20项研究符合纳入标准。我们发现VUR的合并患病率为8.2%(95%CI = 3.6 - 12.7),与一般儿科人群相比增加了约三倍。VUR发生在与UPJO同侧或对侧肾脏的比例为5.7%(95%CI = 3.0 - 8.5),相当于所有VUR患儿的75%。考虑到抗生素治疗VUR的效应大小,分别约需要207名和278名儿童接受VCUG检查,以预防1 - 2年内发生一次发热性UTI和一例肾瘢痕形成。
在此背景下,需要对VUR筛查进行仔细审查并限制在选定的风险组。已知信息:• 根据少数被反复引用的研究,建议对肾盂输尿管连接部梗阻(UPJO)患者进行膀胱输尿管反流(VUR)筛查。• 缺乏确凿证据导致了不同的治疗策略,并在向家长传达诊断和治疗方案时造成困难。新发现:• 根据所有已发表的证据给出了UPJO患儿中VUR的可靠患病率以及由此得出的筛查所需数量,以便在日常临床实践中进行决策。• 这些结果可能是纳入指南的先兆。